Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study

• Main Authors: Merve Sivridaş (Author), Rob H. Creemers (Author), Dennis R. Wong (Author), Paul J. Boekema (Author), Tessa E. H. Römkens (Author), Lennard P. L. Gilissen (Author), Adriaan A. van Bodegraven (Author), Floris C. Loeff (Author), Theo Rispens (Author), Luc J. J. Derijks (Author)
• Format: Book
• Published: MDPI AG, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

There are limited data on therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD) patients treated with vedolizumab (VDZ). Although an exposure-response relation has been demonstrated in the post-induction phase, this relationship is more uncertain in the maintenance phase of treatment...